Medical/Pharmaceuticals
S-CELL Becomes the First in Asia to Introduce Consumer Epigenetics Testing and is the Most Advanced Test in the World
HONG KONG, Feb. 21, 2020 /PRNewswire/ -- S-CELL, in partnership with Chronomics, is the first company inAsia to introduce Healthspan, the most advanced epigenetic testing service in the world. Chronomics was established in 2017 and later officially launched the epigenetics testing kit in hopes to...
2020-02-21 09:20
2224
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
AUSTIN, Texas, Feb. 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2019. Volition management will host a conference call tomorrow,February 21, at 8:30 a.m. U.S. Easte...
2020-02-21 05:10
10107
StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment
BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...
2020-02-20 20:04
1413
Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region
HONG KONG, Feb. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu (HK) Biopharmaceutical Limited (''Xuanzhu''), a wholly-owned subsidiary of the...
2020-02-20 18:59
13135
111 Partners with Financial Institutions in Battle Against Coronavirus
SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...
2020-02-20 17:00
5342
Ten billion investment to build Chengdu medical city to create a new highland for the international health industry
CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...
2020-02-20 16:04
772
Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...
2020-02-20 15:15
1599
InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward
STOCKHOLM, Feb. 20, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate...
2020-02-20 06:00
1666
Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ -- Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...
2020-02-20 01:00
1988
NeuroVive Pharmaceutical AB Year End Report January - December 2019
STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333 * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study * NeuroVive compl...
2020-02-19 16:08
6311
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunctio...
2020-02-19 05:10
10246
Transcenta Achieves Major Milestone in Continuous Perfusion Cell Culture Platform to Provide Industry Leading Productivity and Speed to Manufacturing
SUZHOU and HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing, today announced it has achieved a major milestone in its continuous perfusion cell cult...
2020-02-19 00:00
756
Covaris launches novel viral RNA extraction kits for swab sample collection devices
- Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs - Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Massachusetts, Feb. 18, 2020 /PRNewswire/ -- Covaris, Inc. tod...
2020-02-18 23:00
2445
Henlius successfully held its fourth Scientific Advisory Board (SAB) meeting
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK, Henlius), a global biologics company specialized in the discovery and development of high-quality and affordable antibodies for the treatment of patients with cancer and autoimmune diseases, recently held its fourth ...
2020-02-18 21:59
6513
Sunon Charity Foundation Donates over $1.43 million to Fight the Novel Coronavirus
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- As the novel coronavirus outbreak in Wuhan spreads, Sunon Charity Foundation acted quickly and in unity to fight against this disease. OnJanuary 28, Sunon provided an initial $1.43million to relief and containment efforts. Leveraging its global network and ...
2020-02-18 21:32
2485
Volition Unveils Its Epigenetic Toolbox
AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that research on its Nu.Q(TM) Capture program has led to the development of a suite of novel epigenetic tools building on the breakthroughs announced last month on its assay platform...
2020-02-18 21:30
8615
Ally Bridge Group Leads US$70 million Investments in Two Israeli Life Science Companies over the Last 2 Months
TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it recently ledUS$70 million investments in two Israeli life science companies over the last 2 months. Each of the two companies is ...
2020-02-18 21:30
1806
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that WuXi Vaccines, its joint venture with Shanghai ...
2020-02-18 18:42
2652
Sihuan Pharmaceutical: Production Approval Granted For Rivastigmine Hydrogen Tartrate Capsule, The First Drug Passing Consistency Evaluation And Levetiracetam Tablet And The First Registration Approval Granted For Midazolam Oromucosal Solution
HONG KONG, Feb. 18, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that rivastigmine hydrogen tartrate capsule and levetiracetam tablet developed by the Group...
2020-02-18 18:07
6954
MMI SpA Appoints Ryan Rhodes as Chief Commercial Officer
CALCI, Italy, Feb. 18, 2020 /PRNewswire/ -- MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the appointment ofRyan Rhodes to the position of Global Chief Commercial Officer. Mr. Rhodes brings nearly 30 years of experience...
2020-02-18 16:00
2220
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6217
